0001140361-16-059043.txt : 20160325 0001140361-16-059043.hdr.sgml : 20160325 20160325161541 ACCESSION NUMBER: 0001140361-16-059043 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151228 FILED AS OF DATE: 20160325 DATE AS OF CHANGE: 20160325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 161529864 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 4/A 1 doc1.xml FORM 4/A X0306 4/A 2015-12-28 2015-12-29 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001309702 HASTINGS PAUL J C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 22.10 2015-12-28 4 A 0 170000 0.00 A 2025-12-27 Common Stock 170000 170000 D This amendment is filed to correct the grant date and exercise price of the option reported as acquired herein. This option was originally reported as acquired on December 27, 2015 at an exercise price of $21.43 per share. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Alicia J. Hager, Attorney-in-Fact for Paul Hastings 2016-03-25